| Theme | Unraveling of the Pathophysiology of Functional Gastrointestinal Disorders and Updated Treatments | |
|---|---|---|
| Title | The Guideline of Functional Dyspepsia from the View Point of the Differences from the Rome III Definition | |
| Publish Date | 2015/02 | |
| Author | Tadayuki Oshima | Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine |
| Author | Hiroto Miwa | Division of Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine |
| [ Summary ] | Fundctional dyspepsia (FD) was defined in the Japanese insurance system in 2013 and acotiamide was indicated as first-line treatment. The situation of medical care for FD in Japan is not same as in other western countries ; patients can easily visit medical institutes under the cover of the insurance system in Japan, and the awareness of Helicobacter pylori is high. Furthermore, many prokinetics and Kampo medicines can be used under the medical insurance system. Using, the "Grading of Recommendations, Assessment, Development and Evaluation (GRADE)" system, "The guideline of functional gastrointestinal disorders 2014 -- functional dyspepsia" was published in April 2014 in Japan. The recognition of functional gastrointestinal disorders and the elucidation of the pathophysiology of FD should progress with the publication of these guidelines. | |